← Back to headlines
NCPE Questions Value of Early Access to New Medicines
The head of the committee recommending new drug approval to the HSE has expressed opposition to early access for medicines if they are not first assessed, citing concerns that many 'don't work very well'.
21 Jun, 12:37 — 21 Jun, 12:37
